The genetic algorithm for breast tumor diagnosis - The case of DNA viruses

The purpose of this study is to determine the bioinformatics between breast tumors and DNA viruses. To extract significant factors for breast tumors, two methods - analysis of variance (ANOVA) and information measurement - are used; then, the results show that human papillomavirus (HPV) is not significant factor. Further, genetic algorithm (GA)-based data mining was submitted to obtain the rule between other DNA viruses and breast cancer/fibroadenoma. The GA rule shows that the effect of breast cancer includes {herpes simplex virus (HSV)-1 (-), human herpesvirus (HHV)-8 (-,+)}, {HSV-1(-)}, or {HHV-8(-)}, and that the effect of fibroadenoma includes {HSV-1(+), HHV-8(+)}, {HSV-1(+)}, or {HHV-8(+)}. Furthermore, the Mantel-Haenszel test shows that GA rules make a distinction between breast cancer and fibroadenoma. Finally, regarding diagnosis cost and accuracy, this study suggests that considering HSV-1 alone or with HHV-8 is optimal, but considering only HHV-8 yields less accurate results.

[1]  Parag C. Pendharkar,et al.  Association, statistical, mathematical and neural approaches for mining breast cancer patterns , 1999 .

[2]  Jill L. King,et al.  Computer-assisted diagnosis of breast cancer using a data-driven Bayesian belief network , 1999, Int. J. Medical Informatics.

[3]  Amado Andrés,et al.  Cancer incidence after immunosuppressive treatment following kidney transplantation. , 2005, Critical reviews in oncology/hematology.

[4]  J. Taubenberger,et al.  Epstein-Barr virus detection in ductal carcinoma of the breast. , 2001, Journal of the National Cancer Institute.

[5]  Jan E Schnitzer,et al.  Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells , 1998, Oncogene.

[6]  C Kamby,et al.  Impact of high-dose chemotherapy on antigen-specific T cell immunity in breast cancer patients. Application of new flow cytometric method , 2002, Bone Marrow Transplantation.

[7]  T Shoji,et al.  Two Cases of Kaposi's Sarcoma Mimicking Stewart-Treves Syndrome Found to be Human Herpesvirus-8 Positive , 2001, The American Journal of dermatopathology.

[8]  Christian Marth,et al.  Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[9]  R. Coffin,et al.  Combination of a second generation genetically modified herpes simplex virus 1 (HSV1) with paclitaxel in the treatment of breast cancer in vitro. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  John Ziegler,et al.  The sero‐epidemiology of Kaposi's sarcoma‐associated herpesvirus (KSHV/HHV‐8) in adults with cancer in Uganda , 2003, International journal of cancer.

[11]  G R Howe,et al.  Risk factors for fibroadenoma: a case-control study in Australia. , 1992, American journal of epidemiology.

[12]  Y-J Chen,et al.  Analysis of TSG101 tumour susceptibility gene transcripts in cervical and endometrial cancers , 1999, British Journal of Cancer.

[13]  D. Gertig,et al.  Cytomegalovirus, Epstein–Barr virus and risk of breast cancer before age 40 years: a case–control study , 2004, British Journal of Cancer.

[14]  John H. Holland,et al.  Adaptation in Natural and Artificial Systems: An Introductory Analysis with Applications to Biology, Control, and Artificial Intelligence , 1992 .

[15]  P. Gattuso,et al.  Demonstration of Epstein-Barr virus in carcinomas of various sites. , 2002, Cancer research.

[16]  Ju-Hsin Tsai,et al.  Association of viral factors with non‐familial breast cancer in Taiwan by comparison with non‐cancerous, fibroadenoma, and thyroid tumor tissues , 2005, Journal of medical virology.

[17]  John J. Grefenstette,et al.  Genetic algorithms and their applications , 1987 .

[18]  Yufei Yuan,et al.  A genetic algorithm for generating fuzzy classification rules , 1996, Fuzzy Sets Syst..

[19]  J. Chu,et al.  In situ detection of Epstein-Barr virus in breast cancer. , 1998, Cancer letters.

[20]  Yen-Zen Wang,et al.  A GA-based methodology to determine an optimal curriculum for schools , 2005, Expert Syst. Appl..

[21]  A. Richardson,et al.  Is breast cancer caused by late exposure to a common virus? , 1997, Medical hypotheses.

[22]  F. Spyratos,et al.  Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas , 2001, British Journal of Cancer.

[23]  D. Nettelbeck,et al.  Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter , 2004, Gene Therapy.

[24]  Nicos Maglaveras,et al.  Mining Association Rules from Clinical Databases: An Intelligent Diagnostic Process in Healthcare , 2001, MedInfo.

[25]  S. D. Hayward,et al.  Lytic Viral Replication as a Contributor to theDetection of Epstein-Barr Virus in BreastCancer , 2003, Journal of Virology.

[26]  Y L Yip,et al.  Evaluation of different lymphoid tissue sources for the construction of human immunoglobulin gene libraries. , 1997, Immunotechnology : an international journal of immunological engineering.

[27]  Fei-Fei Liu,et al.  Kinase-dead PKB gene therapy combined with hyperthermia for human breast cancer , 2004, Cancer Gene Therapy.

[28]  David Coley,et al.  Introduction to Genetic Algorithms for Scientists and Engineers , 1999 .

[29]  Akimasa Nakao,et al.  Oncolytic viral therapy for breast cancer with herpes simplex virus type 1 mutant HF 10 , 2004, Journal of surgical oncology.

[30]  Sou-Sen Leu,et al.  A GA-based fuzzy optimal model for construction time-cost trade-off , 2001 .

[31]  Alan Wolfman,et al.  Cloning of TACC1, an embryonically expressed, potentially transforming coiled coil containing gene, from the 8p11 breast cancer amplicon , 1999, Oncogene.

[32]  David E. Goldberg,et al.  Genetic Algorithms in Search Optimization and Machine Learning , 1988 .

[33]  Kyung-shik Shin,et al.  A genetic algorithm application in bankruptcy prediction modeling , 2002, Expert Syst. Appl..

[34]  H Peng,et al.  Human papillomavirus DNA is present in a subset of unselected breast cancers. , 2001, Journal of human virology.

[35]  R. Martuza,et al.  Biological purging of breast cancer cells using an attenuated replication-competent herpes simplex virus in human hematopoietic stem cell transplantation. , 2001, Cancer research.

[36]  J. Vos,et al.  A hybrid herpesvirus infectious vector based on Epstein-Barr virus and herpes simplex virus type 1 for gene transfer into human cells in vitro and in vivo , 1996, Journal of virology.

[37]  Hakan Akbulut,et al.  Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon , 2003, Cancer Gene Therapy.

[38]  S. H. Cheng,et al.  Unique features of breast cancer in Taiwan , 2000, Breast Cancer Research and Treatment.

[39]  Y M Wang,et al.  Production of anti-tumor human monoclonal antibodies using different approaches. , 1993, Human antibodies and hybridomas.

[40]  B. Petrini,et al.  Immunologic monitoring in breast cancer patients receiving postoperative adjuvant chemotherapy , 1981, Cancer.

[41]  H Thierens,et al.  Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers , 2004, International journal of radiation biology.

[42]  B E Griffin,et al.  Epstein–Barr virus gene expression in human breast cancer: protagonist or passenger? , 2003, British Journal of Cancer.

[43]  V. Band,et al.  Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Jennifer Hu,et al.  274. Combination of a Second Generation Genetically Modified Herpes Simplex Virus 1 (HSV 1) with Paclitaxel in the Treatment of Breast Cancer In Vitro , 2004 .

[45]  M Katano,et al.  Inhibition of tumor cell growth by a human B-cell line , 1994, Biotherapy.

[46]  Ingoo Han,et al.  The discovery of experts' decision rules from qualitative bankruptcy data using genetic algorithms , 2003, Expert Syst. Appl..

[47]  Lawrence. Davis,et al.  Handbook Of Genetic Algorithms , 1990 .

[48]  Andrew Bell,et al.  Reactivity with A monoclonal antibody to Epstein-Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome. , 2003, Cancer research.

[49]  A M Nomura,et al.  Migration patterns and breast cancer risk in Asian-American women. , 1993, Journal of the National Cancer Institute.

[50]  L. Ramalho,et al.  Does the correlation between EBNA-1 and p63 expression in breast carcinomas provide a clue to tumorigenesis in Epstein-Barr virus-related breast malignancies? , 2004, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[51]  David E. Goldberg,et al.  Genetic Algorithms with Sharing for Multimodalfunction Optimization , 1987, ICGA.

[52]  B E Griffin,et al.  Epstein-Barr virus in epithelial cell tumors: a breast cancer study. , 1995, Cancer research.

[53]  K Hemminki,et al.  Re: detection of Epstein-Barr virus in invasive breast cancers. , 1999, Journal of the National Cancer Institute.

[54]  Fabio Parazzini,et al.  Oral Contraceptives and Cancer , 1996, Drug safety.

[55]  S. Glaser,et al.  Absence of Epstein‐Barr virus EBER‐1 transcripts in an epidemiologically diverse group of breast cancers , 1998, International journal of cancer.

[56]  G. Klein,et al.  Surveillance against tumors--is it mainly immunological? , 2005, Immunology letters.